Login
Home
Charts
Search
Watchlist
Products

Mono Pharmacare Ltd

MONOPHARMA·NSE
₹8.20-0.61%Wed, 23 Sept '26
Industry:Pharmaceuticals Bulk Drugs & Formulation
Indices:

Mono Pharmacare Ltd

MONOPHARMA
NSE
₹8.20
-0.61%
|Wed, 23 Sept '26
SOICxStockScans Reports
Industry
Pharmaceuticals Bulk Drugs & Formulation
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹14Cr
Close
Close Price
₹8.20
Industry
Industry
Pharmaceuticals Bulk Drugs & Formulation
PE
Price To Earnings
41.00
PS
Price To Sales
0.09
Revenue
Revenue
₹166Cr
Rev Gr TTM
Revenue Growth TTM
-1.57%
PAT Gr TTM
PAT Growth TTM
-88.78%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
35675687816699
Growth YoY
Revenue Growth YoY%
59.331.045.5-23.922.4
Expenses
ExpensesCr
33635382786597
Operating Profit
Operating ProfitCr
2425322
OPM
OPM%
5.75.84.45.43.62.72.2
Other Income
Other IncomeCr
0000100
Interest Expense
Interest ExpenseCr
1222222
Depreciation
DepreciationCr
0000000
PBT
PBTCr
1213101
Tax
TaxCr
0101100
PAT
PATCr
1212100
Growth YoY
PAT Growth YoY%
-7.823.039.0-99.1-59.8
NPM
NPM%
1.82.81.12.61.00.00.3
EPS
EPS₹
0.01.40.41.30.50.00.2
QuarterMar 2023Sep 2023Mar 2024Sep 2024Mar 2025Sep 2025Mar 2026
Revenue
RevenueCr
35675687816699
Growth YoY
Revenue Growth YoY%
59.331.045.5-23.922.4
Expenses
ExpensesCr
33635382786597
Operating Profit
Operating ProfitCr
2425322
OPM
OPM%
5.75.84.45.43.62.72.2
Other Income
Other IncomeCr
0000100
Interest Expense
Interest ExpenseCr
1222222
Depreciation
DepreciationCr
0000000
PBT
PBTCr
1213101
Tax
TaxCr
0101100
PAT
PATCr
1212100
Growth YoY
PAT Growth YoY%
-7.823.039.0-99.1-59.8
NPM
NPM%
1.82.81.12.61.00.00.3
EPS
EPS₹
0.01.40.41.30.50.00.2

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
33122168166
Growth
Revenue Growth%
269.837.6-1.6
Expenses
ExpensesCr
31116161162
Operating Profit
Operating ProfitCr
2684
OPM
OPM%
6.85.24.52.4
Other Income
Other IncomeCr
0010
Interest Expense
Interest ExpenseCr
1343
Depreciation
DepreciationCr
0000
PBT
PBTCr
1341
Tax
TaxCr
0110
PAT
PATCr
1230
Growth
PAT Growth%
160.126.3-88.7
NPM
NPM%
2.92.01.80.2
EPS
EPS₹
0.81.61.80.2
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
33122168166
Growth
Revenue Growth%
269.837.6-1.6
Expenses
ExpensesCr
31116161162
Operating Profit
Operating ProfitCr
2684
OPM
OPM%
6.85.24.52.4
Other Income
Other IncomeCr
0010
Interest Expense
Interest ExpenseCr
1343
Depreciation
DepreciationCr
0000
PBT
PBTCr
1341
Tax
TaxCr
0110
PAT
PATCr
1230
Growth
PAT Growth%
160.126.3-88.7
NPM
NPM%
2.92.01.80.2
EPS
EPS₹
0.81.61.80.2

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2023Mar 2024Mar 2025
Equity Capital
Equity CapitalCr
121818
Reserves
ReservesCr
11014
Current Liabilities
Current LiabilitiesCr
343653
Non Current Liabilities
Non Current LiabilitiesCr
151726
Total Liabilities
Total LiabilitiesCr
6381110
Current Assets
Current AssetsCr
6180109
Non Current Assets
Non Current AssetsCr
111
Total Assets
Total AssetsCr
6381110
Financial YearMar 2023Mar 2024Mar 2025
Equity Capital
Equity CapitalCr
121818
Reserves
ReservesCr
11014
Current Liabilities
Current LiabilitiesCr
343653
Non Current Liabilities
Non Current LiabilitiesCr
151726
Total Liabilities
Total LiabilitiesCr
6381110
Current Assets
Current AssetsCr
6180109
Non Current Assets
Non Current AssetsCr
111
Total Assets
Total AssetsCr
6381110

Cash Flow

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-40-9-42
Investing Cash Flow
Investing Cash FlowCr
-1000
Financing Cash Flow
Financing Cash FlowCr
4185-2
Net Cash Flow
Net Cash FlowCr
0000
Free Cash Flow
Free Cash FlowCr
-40-9-5
CFO To PAT
CFO To PAT%
-4,182.8-356.8-138.5657.1
CFO To EBITDA
CFO To EBITDA%
-1,765.9-138.6-56.357.6
Financial YearMar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-40-9-42
Investing Cash Flow
Investing Cash FlowCr
-1000
Financing Cash Flow
Financing Cash FlowCr
4185-2
Net Cash Flow
Net Cash FlowCr
0000
Free Cash Flow
Free Cash FlowCr
-40-9-5
CFO To PAT
CFO To PAT%
-4,182.8-356.8-138.5657.1
CFO To EBITDA
CFO To EBITDA%
-1,765.9-138.6-56.357.6

Ratios

Consolidated
Standalone
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
78412014
Price To Earnings
Price To Earnings
32.013.256.341.0
Price To Sales
Price To Sales
0.60.20.10.1
Price To Book
Price To Book
2.81.30.60.5
EV To EBITDA
EV To EBITDA
18.812.317.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
11.69.59.4
OPM
OPM%
6.85.24.52.42.4
NPM
NPM%
2.92.01.80.20.2
ROCE
ROCE%
4.29.110.0
ROE
ROE%
6.98.810.0
ROA
ROA%
1.53.02.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
78412014
Price To Earnings
Price To Earnings
32.013.256.341.0
Price To Sales
Price To Sales
0.60.20.10.1
Price To Book
Price To Book
2.81.30.60.5
EV To EBITDA
EV To EBITDA
18.812.317.6
Profitability Ratios
Profitability Ratios
GPM
GPM%
11.69.59.4
OPM
OPM%
6.85.24.52.42.4
NPM
NPM%
2.92.01.80.20.2
ROCE
ROCE%
4.29.110.0
ROE
ROE%
6.98.810.0
ROA
ROA%
1.53.02.8
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Mono Pharmacare Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/4injoexbptibfsu8wcpvkvqu.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/ry3x3cdljp9h0iox3qtjciqe.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/hpelytenxoua6efwx2tcqmpd.pdf
  • Q4 FY2024 Quarterly Result (Mar 2024, PDF): https://www.stockscans.in/document/1mhk65fnjmj4arq4g4u69ctj.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/r5zfbufgptliqd39zojsnk75.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/y5i831yjz1d70mrihw0yfaqq.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies